NKMax America Expands Operations in Santa Ana, California
09/10/2019
The biotech company specializes in both autologous and allogenic Natural Killer (NK) cell therapy utilizing proprietary cell expansion and cell activation technology. This therapeutic technology was developed as a complement to NKMax's first-in-kind in vitro diagnostic test which measures NK cell activity using only one milliliter of whole blood.
According to company officials, the new facility will house the U.S. operations for NKMax and includes administrative offices, a CLIA-certified, CAP-accredited clinical laboratory in addition to cGMP manufacturing capabilities. The flagship facility represents NKMax's commitment to meeting production demands for the SNK cell therapy clinical trials and ultimately for commercial manufacturing.
"The new GMP facility builds on our technical capabilities and rapid progress towards advancing NK cell therapies," commented Stephen Chen, MBA, CTO of NKMax America. "We have designed and built a state-of-the-art facility around our innovative manufacturing processes that enables us to produce clinical and commercial NK cell therapies."
Following occupancy, the company will be taking the next few months to secure the appropriate licensing and wrap up final validation activities before the first official product release, officials said.
Project Announcements
South Korea-Based SPC Group Plans Burleson, Texas, Production Operations
02/05/2025
Diageo North America Plans Montgomery, Alabama, Manufacturing-Warehouse Operations
02/05/2025
Octillion Power Systems Establishes Reno, Nevada, Battery Manufacturing Operations
02/05/2025
Letica Expands Fulton County, Kentucky, Operations
02/05/2025
Japan-Based Murakami Manufacturing USA Expands Taylor County, Kentucky, Operations
02/05/2025
Hex Armor Expands Grand Rapids, Michigan, Operations
02/05/2025
Most Read
-
2024's Leading Metro Locations: U.S. Cities on the Rise Amid an Economic Reshuffling
Q4 2024
-
The Workforce Factor: How States Are Competing to Build Tomorrow's Talent
Q4 2024
-
Best Practices in Incentives Procurement
Q4 2024
-
Five Strategies to Tackle the Data Center Talent Shortage
Q4 2024
-
Microsoft-Three Mile Island Deal Could Signal Path for Nuclear Power to Strengthen Partnerships with Big Tech
Q4 2024
-
Industries Look for Employees in Nontraditional Spaces Amid Labor Shortage
Q4 2024
-
Why Decarbonization Goals Start with Site Selection
Q4 2024